<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04801368</url>
  </required_header>
  <id_info>
    <org_study_id>20-010842</org_study_id>
    <nct_id>NCT04801368</nct_id>
  </id_info>
  <brief_title>A Study to Analyze the Effects of Exparel for Post-Surgery Pain Control in Patients Undergoing Penile Prosthesis Placement</brief_title>
  <official_title>A Randomized-Controlled Trial Comparing Long-acting and Short-acting Local Anesthetics at the Time of Penile Prosthesis Placement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to determine the effects of penile ring block for local&#xD;
      anesthesia with liposomal bupivacaine vs ropivacaine mixture in subjects undergoing surgery&#xD;
      for Penile Prosthesis Placement.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The two anesthetics being used in the study are FDA approved and used in standard practice for the procedure.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patient is blind to local anesthetic being administered.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Visual-analogue pain scale</measure>
    <time_frame>post-operative day 1</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no pain, 10 being the most pain. 0 being the best outcome, 10 being the worst outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual-analogue pain scale</measure>
    <time_frame>post-operative day 3</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no pain, 10 being the most pain. 0 being the best outcome, 10 being the worst outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual-analogue pain scale</measure>
    <time_frame>post-operative day 7</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no pain, 10 being the most pain. 0 being the best outcome, 10 being the worst outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual-analogue pain scale</measure>
    <time_frame>post-operative day 14</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no pain, 10 being the most pain. 0 being the best outcome, 10 being the worst outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual-analogue anxiety scale</measure>
    <time_frame>post-operative day 1</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no anxiety, 10 being the most anxiety. 0 being the best outcome, 10 being the worst outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual-analogue anxiety scale</measure>
    <time_frame>post-operative day 3</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no anxiety, 10 being the most anxiety. 0 being the best outcome, 10 being the worst outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual-analogue anxiety scale</measure>
    <time_frame>post-operative day 7</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no anxiety, 10 being the most anxiety. 0 being the best outcome, 10 being the worst outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual-analogue anxiety scale</measure>
    <time_frame>post-operative day 14</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-10, 0 being no anxiety, 10 being the most anxiety. 0 being the best outcome, 10 being the worst outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>State Trait Anxiety Inventory</measure>
    <time_frame>post-operative day 1</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-4 answering 20 questions. 1 being not at all, 2 being a little, 3 being somewhat, 4 being very much so. Best outcome varies with each question.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>State Trait Anxiety Inventory</measure>
    <time_frame>post-operative day 3</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-4 answering 20 questions. 1 being not at all, 2 being a little, 3 being somewhat, 4 being very much so. Best outcome varies with each question.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>State Trait Anxiety Inventory</measure>
    <time_frame>post-operative day 7</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-4 answering 20 questions. 1 being not at all, 2 being a little, 3 being somewhat, 4 being very much so. Best outcome varies with each question.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>State Trait Anxiety Inventory</measure>
    <time_frame>post-operative day 14</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 1-4 answering 20 questions. 1 being not at all, 2 being a little, 3 being somewhat, 4 being very much so. Best outcome varies with each question.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Catastrophizing scale</measure>
    <time_frame>post-operative day 1</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 0-4 answering 20 questions. 0 being not at all, 1 being to a slight degree, 2 being to a moderate degree, 3 being to a great degree, 4 being all the time. Best outcome varies with each question.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Catastrophizing scale</measure>
    <time_frame>post-operative day 3</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 0-4 answering 20 questions. 0 being not at all, 1 being to a slight degree, 2 being to a moderate degree, 3 being to a great degree, 4 being all the time. Best outcome varies with each question.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Catastrophizing scale</measure>
    <time_frame>post-operative day 7</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 0-4 answering 20 questions. 0 being not at all, 1 being to a slight degree, 2 being to a moderate degree, 3 being to a great degree, 4 being all the time. Best outcome varies with each question.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Catastrophizing scale</measure>
    <time_frame>post-operative day 14</time_frame>
    <description>Patients will answer this questionnaire at 4 separate time points. Scale of 0-4 answering 20 questions. 0 being not at all, 1 being to a slight degree, 2 being to a moderate degree, 3 being to a great degree, 4 being all the time. Best outcome varies with each question.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Receiving Ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving Ropivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Receiving Liposomal Bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving Liposomal Bupivacaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Randomization of two local anesthetics.</intervention_name>
    <description>Patients will be blinded and randomized to two different arms. One receiving ropivacaine, one receiving liposomal bupivacaine.</description>
    <arm_group_label>Receiving Liposomal Bupivacaine</arm_group_label>
    <arm_group_label>Receiving Ropivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men undergoing 3-piece penile prosthesis placement under general anesthesia at Mayo&#xD;
             Clinic - Rochester.&#xD;
&#xD;
          -  â‰¥ 18 years old.&#xD;
&#xD;
        Exclusion Citeria:&#xD;
&#xD;
          -  History of opioid exposure within the preceding 90 days prior to surgery (based on&#xD;
             patient-report, review of the electronic medical record, and NMP prescribing database&#xD;
             review)&#xD;
&#xD;
          -  Current or prior history of alcohol or drug abuse (illicit or prescription)&#xD;
&#xD;
          -  History of chronic pain conditions (chronic musculoskeletal pain, fibromyalgia,&#xD;
             central sensitization, chronic pelvic pain syndrome, etc.)&#xD;
&#xD;
          -  History of cardiac arrhythmia or untreated severe cardiovascular disease&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  Hepatic insufficiency&#xD;
&#xD;
          -  Renal insufficiency (CKD stage IIIa or greater)&#xD;
&#xD;
          -  Current anti-platelet or anti-coagulation therapy with plans to continue at the time&#xD;
             of prosthesis placement&#xD;
&#xD;
          -  Poorly controlled diabetes mellitus (defined as HgbA1c &gt; 8.5 within 30 days of&#xD;
             surgery)&#xD;
&#xD;
          -  Concurrent adjunctive operative procedures planned at the time of penile prosthesis&#xD;
             placement (examples: male urethral sling, Peyronie's disease straightening with penile&#xD;
             plication or incision/grafting)&#xD;
&#xD;
          -  Concurrent non-prosthetic surgery planned at the time of penile prosthesis placement&#xD;
             (examples: circumcision, hernia repair, hydrocelectomy, etc.)&#xD;
&#xD;
          -  Planned infrapubic or subcoronal incision at the time of penile prosthesis placement&#xD;
&#xD;
          -  Patients who will be undergoing prosthesis placement using local, monitored, or spinal&#xD;
             anesthesia (i.e. non-general anesthesia)&#xD;
&#xD;
          -  Allergy or history of intolerance to any local anesthetic agents included in the&#xD;
             protocol&#xD;
&#xD;
          -  History of prior penile prosthesis or artificial urinary sphincter surgery&#xD;
&#xD;
          -  Revision penile prosthesis surgery&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew J Ziegelmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alex Ferguson</last_name>
    <phone>507-422-5102</phone>
    <email>Ferguson.Alex@mayo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 19, 2021</study_first_submitted>
  <study_first_submitted_qc>March 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2021</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Matthew (Matt) J. Ziegelmann</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

